A Bright Tomorrow for Therapeutic Orphans: The Potential for New Approach Methodologies to Bridge Data Gaps for Pregnant Patients
By Matthew Durthaler | July 24th, 2025
“As caution often precludes pregnant humans from serving as models of their own physiology, various non-human animal models have been employed. While these models have displayed some value, they are severely limited by interspecies variation and thus serve as subpar predictors of gravid human physiology.”
Sonogram captured by Matthew Durthaler, used with permission
Unleashing Innovation: The Business Case for New Approach Methods (NAMs)
By Zachary Liebowitz | January 23rd, 2025
“As we stand on the cusp of a new era in science and industry, the case for NAMs is clear. They are more than a set of tools—they represent a paradigm shift that aligns innovation with ethical responsibility and economic growth.“
Revolutionizing Healthcare: How Induced Pluripotent Stem Cells are Paving the Way for Personalized Medicine
By Zachary Liebowitz | May 30th, 2024
“Not only is this model of personalized medicine more clinically relevant than today’s approaches, it is simultaneously more humane, time effective, and cost efficient.”